ArticlePLoS pathogens2026

Correction: Immune-focused RBD nanoparticles induce cross-reactive, RBS-directed responses capable of variant-resistant SARS-CoV-2 neutralization.

Kylie M Konrath et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.